Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia

被引:14
作者
Kizaki, M [1 ]
Muto, A [1 ]
Kinjo, K [1 ]
Ueno, H [1 ]
Ikeda, Y [1 ]
机构
[1] Keio Univ, Sch Med, Div Hematol, Shinjuku Ku, Tokyo 1608582, Japan
关键词
D O I
10.1093/jnci/90.24.1906
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1906 / 1907
页数:2
相关论文
共 7 条
[1]  
Chen GQ, 1996, BLOOD, V88, P1052
[2]   Establishment of a retinoic acid resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM CSF) transgenic severe combined immunodeficiency (SCID) mice [J].
Fukuchi, Y ;
Kizaki, M ;
Kinjo, K ;
Awaya, N ;
Muto, A ;
Ito, M ;
Kawai, Y ;
Umezawa, A ;
Hata, J ;
Ueyama, Y ;
Ikeda, Y .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :878-884
[3]  
Kizaki M, 1996, BLOOD, V88, P1824
[4]   Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells [J].
Shao, WL ;
Fanelli, M ;
Ferrara, FF ;
Riccioni, R ;
Rosenauer, A ;
Davison, K ;
Lamph, WW ;
Waxman, S ;
Pelicci, PG ;
Lo Coco, F ;
Avvisati, G ;
Testa, U ;
Peschle, C ;
Gambacorti-Passerini, C ;
Nervi, C ;
Miller, WH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (02) :124-133
[5]   Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].
Shen, ZX ;
Chen, GQ ;
Ni, JH ;
Li, XS ;
Xiong, SM ;
Qiu, QY ;
Zhu, J ;
Tang, W ;
Sun, GL ;
Yang, KQ ;
Chen, Y ;
Zhou, L ;
Fang, ZW ;
Wang, YT ;
Ma, J ;
Zhang, P ;
Zhang, TD ;
Chen, SJ ;
Chen, Z ;
Wang, ZY .
BLOOD, 1997, 89 (09) :3354-3360
[6]   Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils [J].
Simon, HU ;
Yousefi, S ;
Dibbert, B ;
Levi-Schaffer, F ;
Blaser, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3536-3539
[7]   ACUTE PROMYELOCYTIC LEUKEMIA [J].
WARRELL, RP ;
DETHE, H ;
WANG, ZY ;
DEGOS, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :177-189